Embryonal central nervous system neoplasms arising in infants and young children: A pediatric brain tumor consortium study

15Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Context.-Medulloblastomas (MBs) and atypical teratoid/rhabdoid tumors (AT/RTs) arising in infants and children can be difficult to distinguish; however, histologic characterization is prognostically important. Objective.-To determine histologic and phenotypic markers associated with utility with progression-free survival (PFS) and overall survival (OS) in children younger than 3 years with MBs and AT/RTs. Design.-We undertook a histologic and immunophenotypic study of MBs and AT/RTs arising in infants and children younger than 3 years treated in a Pediatric Brain Tumor Consortium study. The 41 girls and 55 boys ranged in age from 2 to 36 months at enrollment. These infants and children exhibited 51 MBs, 26 AT/RTs, and 24 other tumors (not further studied). Median follow-up of the patients was 17.2 months from diagnosis (range: 1.4-93 months). Results.-Infants and children with AT/RT exhibited a statistically significant shorter PFS and OS when compared to infants and children with MBs (both P

Cite

CITATION STYLE

APA

McLendon, R. E., Adekunle, A., Rajaram, V., Koçak, M., & Blaney, S. M. (2011). Embryonal central nervous system neoplasms arising in infants and young children: A pediatric brain tumor consortium study. Archives of Pathology and Laboratory Medicine, 135(8), 984–993. https://doi.org/10.5858/2010-0515-OAR1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free